⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma

Official Title: Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma - A Randomised Phase III Trial

Study ID: NCT01503827

Interventions

WBRT

Study Description

Brief Summary: People with brain metastases from melanoma are offered different treatment options after local treatment of their brain metastases via surgery or stereotactic irradiation. Depending on the treating institution and the clinician involved a patient may or may not be offered whole brain radiotherapy (WBRT) after their brain metastases are excised or treated with stereotactic irradiation. This trial seeks to determine if WBRT reduces the spread of brain metastases and lengthens the time to recurrence. The trial also examines the effect of WBRT on quality of life and brain functions such as memory, speech and concentration. Participants will be randomised after local treatment of their brain metastases to either WBRT or observation. 220 people will be recruited from sites in Australia, Norway, the UK, the US and other international sites.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

St Vincent's Hospital, Darlinghurst, New South Wales, Australia

Calvary Mater Hospital, Newcastle, New South Wales, Australia

Genesis Cancer Care - Gateshead, Newcastle, New South Wales, Australia

Melanoma Institute Australia / Royal Prince Alfred Hospital, North Sydney, New South Wales, Australia

Nepean Hospital, Penrith, New South Wales, Australia

Westmead Hospital, Westmead, New South Wales, Australia

Darwin Hospital, NT Radiation Oncology, Darwin, Northern Territory, Australia

Royal Brisbane and Women's Hospital, Herston, Queensland, Australia

Radiation Oncology Services - Mater Centre, South Brisbane, Queensland, Australia

Townsville Hospital, Townsville, Queensland, Australia

Genesis Cancer Care - Tugun, Tugun, Queensland, Australia

Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

Royal Adelaide Hospital, Adelaide, South Australia, Australia

Royal Hobart Hospital, Hobart, Tasmania, Australia

Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia

Alfred Hospital, Melbourne, Victoria, Australia

Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia

The Norwegian Radium Hospital, Oslo, , Norway

Velindre Hospital, Whitchurch, Cardiff, United Kingdom

Mount Vernon Cancer Centre, Northwood, Middlesex, United Kingdom

Churchill Hospital, Headington, Oxford, United Kingdom

St. James University Hospital, Leeds, , United Kingdom

Norfolk & Norwich University Hospital, Norwich, , United Kingdom

Contact Details

Name: Gerald Fogarty, BSc, MBBS

Affiliation: Mater Hospital, St Vincent's Hospital, Melanoma Institue Australia

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: